Safety of JN.1-updated mRNA COVID-19 vaccines

JAMA Network Open

2025-07-28

(Press-News.org) About The Study: In this nationwide cohort study, no increased risk of 29 adverse events was observed after vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage in approximately 1 million adults.

Corresponding Author: To contact the corresponding author, Niklas Worm Andersson, MD, PhD, email nian@ssi.dk.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.23557)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.23557?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072825

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Type 2 diabetes and financial outcomes

2025-07-28

About The Study: The findings of this study suggest that patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes, highlighting the need to consider patient financial health when treating type 2 diabetes, particularly for patient groups at higher risk. Corresponding Author: To contact the corresponding author, Cazilia Loibl, PhD, CFP, email loibl.3@osu.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2025.23453) Editor’s ...

A financial toll on patients with type 2 diabetes

2025-07-28

Embargoed until 11 a.m. ET, July 28, 2025 In a first-of-its-kind study, researchers used a unique dataset to show that patients with type 2 diabetes have significantly worse financial outcomes than other patients. Findings showed diabetes patients fared worse on all seven financial outcomes studied, including below-prime credit scores, medical and non-medical debt in collections, 60-plus-day delinquent debt, debt charge-offs, bankruptcy filings and foreclosure. The diabetes patients in this study were compared to people who had a blood test ...

Safflower yellow pigments in coronary heart disease: Mechanisms, applications, and future perspectives

2025-07-28

Coronary heart disease (CHD), characterized by atherosclerosis-induced myocardial ischemia, remains a leading cause of mortality in China. Safflower yellow pigments (SYPs), the primary bioactive components of Carthamus tinctorius L., consist mainly of quinochalcone C-glycosides, with hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) as key constituents. This review synthesizes evidence on SYPs' mechanisms, therapeutic applications, and future directions in CHD management. Chemical Composition and Pharmacokinetics SYPs comprise over 20 identified compounds, including HSYA and AHSYB, which confer cardiovascular protection, anti-inflammatory, and antioxidant activities. ...

TraMA: new RNA-based measure predicts mortality risk and tracks aging

2025-07-28

“TraMA is likely to be of particular value to researchers interested in understanding the biological processes underlying health and aging, and for social, psychological, epidemiological, and demographic studies of health and aging.” BUFFALO, NY — July 28, 2025 — A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on June 13, 2025, titled “Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA).” In ...

From WebMD to AI chatbots: How innovation has empowered patients to take control of their health

2025-07-28

TORONTO, ON July 28, 2025 A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care system. The paper, titled "From Internet to Artificial Intelligence (Al) Bots: Symbiotic Evolutions of Digital Technologies and e-Patients," explores the symbiotic evolution of digital health tools and the increasingly engaged e-patient. The concept of the e-patient, defined as an individual "equipped, enabled, empowered, and engaged" in their health, has been propelled forward by advancements spanning ...

Unravelling antileishmanial mechanisms of phytochemicals: From mitochondrial disruption to immunomodulation

2025-07-28

Leishmaniasis, a neglected tropical disease caused by Leishmania parasites, affects millions globally. Current synthetic treatments face limitations including toxicity, cost, and resistance. Phytochemicals from medicinal plants offer promising alternatives. This mini-review synthesizes preclinical mechanisms of plant-derived compounds against leishmaniasis, focusing on mitochondrial disruption, immunomodulation, and redox imbalance. Key Antileishmanial Mechanisms 1. Membrane Disruption & ...

Association for Molecular Pathology announces 2025 award recipients

2025-07-28

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards. These prestigious honors will be presented in November during the AMP 2025 Annual Meeting & Expo in Boston. Award for Excellence in Molecular Diagnostics Elaine R. Mardis, Ph.D. Co-executive Director, Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital Rasmussen Nationwide Foundation Endowed Chair in Genomic ...

When light collides with light

2025-07-28

Usually, light waves can pass through each other without any resistance. According to the laws of electrodynamics, two light beams can exist in the same place without influencing each other; they simply overlap. Light saber battles, as seen in science fiction films, would therefore be rather boring in reality. Nevertheless, quantum physics predicts the effect of “light-on-light scattering”. Ordinary lasers are not powerful enough to detect it, but it has been observed at the CERN particle accelerator. Virtual particles can literally emerge from nothing for a short time, interact with the photons and change their direction. The effect is extremely small, ...

Study finds that white students visit college advisers the least, but benefit most in terms of graduation rates and GPA

2025-07-28

A new study finds that White students visit academic advisers the least, but have the highest academic benefits, in terms of GPA and graduation rates, compared to nonwhite students and international students. In higher education, substantial gaps exist between White and nonwhite students, with a greater number of White students graduating in fewer years and receiving higher grades than many other groups. Prior research shows that nonwhite students are less likely to engage with faculty members, but there is a dearth of information related to interactions with academic advisers—staffers ...

Science by the millions: How everyday people are revolutionizing global biodiversity research with tech

2025-07-28

A frog croaks from a walking trail. A hiker snaps a photo and uploads it to iNaturalist. That single act — one person, one amphibian and one click — feeds into a growing global dataset that scientists now use to map shifting species ranges, detect invasive threats and even discover new species. An international study led by researchers at the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) shows how iNaturalist, the global technology platform through which everyday people share ...

Safety of JN.1-updated mRNA COVID-19 vaccines

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: